Astrocytes are versatile glial cells that regulate diverse processes in the central nervous system (CNS). Roles for astrocytes during disease are complex and include both protective and pathologic functions. Recently, distinct astrocyte activation states have been described, though the molecular mechanisms that govern astrocyte polarization during neurotropic viral infection are not well understood. Here, we propose that receptor-interacting protein kinase-3 (RIPK3) is a previously unappreciated driver of inflammatory astrocyte activation during viral infection of the CNS. While roles for RIPK3 in programmed cell death have been extensively characterized, our published work has described pleiotropic, cell death-independent functions for this pathway in the coordination of protective neuroinflammation during viral encephalitis. In preliminary studies, we now show that RIPK3 signaling in astrocytes is required for survival and virologic control following challenge with Zika virus, an emerging neurotropic pathogen of global concern. Using a combination of novel mouse genetic tools, we will elucidate roles for RIPK3 signaling in astrocytes by 1) Defining profiles of expression, activation, and antiviral function for astrocytic RIPK3; 2) Determining roles for astrocytic RIPK3 signaling in coordinating neuroinflammation; and 3) Defining key substrates and transcriptional outputs of RIPK3 signaling in astrocytes. Together, our studies promise to identify new molecular mechanisms governing protective neuroimmune function during viral encephalitis.

Public Health Relevance

Neurotropic flaviviruses, including Zika virus, are a growing threat to global health. Despite the increasing burden of neurologic injury and cognitive impairment associated with flavivirus encephalitis, no disease-specific therapies for these infections exist. Here, we aim to identify new molecular mechanisms that promote protective neuroimmune function during Zika virus infection of the brain. These findings would uncover much-needed new molecular targets for the development of therapeutic and intervention strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS120895-01
Application #
10174146
Study Section
Cellular and Molecular Biology of Glia Study Section (CMBG)
Program Officer
Wong, May
Project Start
2021-02-15
Project End
2026-01-31
Budget Start
2021-02-15
Budget End
2022-01-31
Support Year
1
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Rutgers University
Department
Type
DUNS #
001912864
City
Piscataway
State
NJ
Country
United States
Zip Code